Tyra

formerly Tyra BiosciencesIPO

Developing Next-Generation Precision Molecules

Public · Carlsbad, United States · Founded 2019 · $356.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$356.0M
Last Round
$106.0M Series BMar 2021
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 4 investors for this company. The full record is or through the API.

About

Tyra Biosciences (Nasdaq: TYRA) is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology to overcome acquired resistance in oncology and genetically defined conditions. The company's proprietary SNÅP platform enables rapid, iterative molecular drug design to predict and preempt genetic alterations that cause resistance to existing therapies. Its lead programs include TYRA-300, a potential first-in-class selective FGFR3 inhibitor, and TYRA-200, an FGFR1/2/3 inhibitor for intrahepatic cholangiocarcinoma.

Summary

Tyra is a Biotech company based in Carlsbad, United States, founded in 2019. It has raised $356.0M in total across 3 rounds, most recently a $106.0M Series B round in Mar 2021. Investors include Alta Partners, RA Capital Management and Boxer Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary Market2024 (est.)

Sign up to see all 6 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tyra on Indexed.vc
<a href="https://indexed.vc/companies/tyra"><img src="https://indexed.vc/api/badge/company/tyra" alt="Tyra on Indexed.vc" width="260" height="76" /></a>